We previously reported that the USP7 inhibitor XL188 acted as a p53 activator in TP53-WT Ewing sarcoma, but studies of USP7 inhibition in other contexts have typically focused on p53-independent mechanisms. Here, USP7 is linked to Ewing sarcoma.